tiprankstipranks
Trending News
More News >
Tenet Healthcare (THC)
NYSE:THC
US Market
Advertisement

Tenet Healthcare (THC) Ratios

Compare
927 Followers

Tenet Healthcare Ratios

THC's free cash flow for Q3 2025 was $0.58. For the 2025 fiscal year, THC's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.71 1.51 1.34 1.38 1.47
Quick Ratio
1.64 1.42 1.25 1.31 1.40
Cash Ratio
0.65 0.26 0.19 0.46 0.50
Solvency Ratio
0.12 0.06 0.08 0.10 0.07
Operating Cash Flow Ratio
0.54 0.50 0.24 0.31 0.70
Short-Term Operating Cash Flow Coverage
29.15 65.94 7.47 11.61 148.13
Net Current Asset Value
$ -12.91B$ -15.64B$ -16.57B$ -16.25B$ -17.07B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.57 0.56 0.57 0.58
Debt-to-Equity Ratio
0.02 10.08 13.20 15.22 561.39
Debt-to-Capital Ratio
0.02 0.91 0.93 0.94 1.00
Long-Term Debt-to-Capital Ratio
0.00 0.90 0.93 0.94 1.00
Financial Leverage Ratio
7.33 17.61 23.78 26.83 968.07
Debt Service Coverage Ratio
7.17 3.29 2.88 2.84 2.46
Interest Coverage Ratio
8.54 2.79 2.62 3.11 1.98
Debt to Market Cap
<0.01 1.93 2.89 1.79 3.68
Interest Debt Per Share
5.59 168.38 149.34 155.09 159.24
Net Debt to EBITDA
-0.77 4.42 4.28 3.89 5.47
Profitability Margins
Gross Profit Margin
55.93%82.53%82.93%82.92%83.10%
EBIT Margin
12.83%12.25%12.96%13.15%8.89%
EBITDA Margin
17.93%16.49%17.35%17.54%13.75%
Operating Profit Margin
16.67%12.22%12.17%14.73%11.28%
Pretax Profit Margin
13.30%7.87%7.01%9.69%3.80%
Net Profit Margin
7.63%2.97%5.22%7.58%4.35%
Continuous Operations Profit Margin
8.23%6.38%5.22%7.58%4.35%
Net Income Per EBT
57.35%37.79%74.40%78.23%114.46%
EBT Per EBIT
79.80%64.42%57.61%65.76%33.74%
Return on Assets (ROA)
5.41%2.16%3.68%5.36%2.83%
Return on Equity (ROE)
39.49%38.00%87.57%143.68%2742.86%
Return on Capital Employed (ROCE)
13.98%10.66%10.29%12.78%8.94%
Return on Invested Capital (ROIC)
12.87%8.52%7.61%9.94%10.08%
Return on Tangible Assets
9.41%3.67%6.41%8.78%4.60%
Earnings Yield
8.65%7.95%19.17%16.92%18.32%
Efficiency Ratios
Receivables Turnover
8.28 5.15 5.54 5.89 5.26
Payables Turnover
6.78 2.55 2.18 2.56 2.47
Inventory Turnover
26.56 8.73 8.08 8.67 8.10
Fixed Asset Turnover
3.42 2.81 2.97 3.03 2.64
Asset Turnover
0.71 0.73 0.71 0.71 0.65
Working Capital Turnover Ratio
6.64 10.51 11.05 9.14 11.11
Cash Conversion Cycle
3.96 -30.44 -56.66 -38.53 -33.36
Days of Sales Outstanding
44.07 70.93 65.90 61.93 69.34
Days of Inventory Outstanding
13.74 41.79 45.16 42.12 45.04
Days of Payables Outstanding
53.86 143.15 167.72 142.58 147.74
Operating Cycle
57.81 112.72 111.07 104.04 114.38
Cash Flow Ratios
Operating Cash Flow Per Share
28.17 23.36 10.13 14.68 32.44
Free Cash Flow Per Share
17.08 15.97 3.00 8.52 27.30
CapEx Per Share
11.10 7.39 7.13 6.16 5.14
Free Cash Flow to Operating Cash Flow
0.61 0.68 0.30 0.58 0.84
Dividend Paid and CapEx Coverage Ratio
2.54 3.16 1.42 2.38 6.31
Capital Expenditure Coverage Ratio
2.54 3.16 1.42 2.38 6.31
Operating Cash Flow Coverage Ratio
29.15 0.15 0.07 0.10 0.22
Operating Cash Flow to Sales Ratio
0.12 0.12 0.06 0.08 0.19
Free Cash Flow Yield
8.13%21.13%6.15%10.43%68.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.56 12.57 5.22 5.91 5.46
Price-to-Sales (P/S) Ratio
0.89 0.37 0.27 0.45 0.24
Price-to-Book (P/B) Ratio
4.58 4.78 4.57 8.49 149.75
Price-to-Free Cash Flow (P/FCF) Ratio
12.30 4.73 16.25 9.59 1.46
Price-to-Operating Cash Flow Ratio
7.42 3.24 4.82 5.57 1.23
Price-to-Earnings Growth (PEG) Ratio
-1.75 -0.34 -0.16 0.07 0.01
Price-to-Fair Value
4.58 4.78 4.57 8.49 149.75
Enterprise Value Multiple
4.17 6.69 5.84 6.44 7.20
Enterprise Value
15.59B 22.67B 19.44B 22.01B 17.47B
EV to EBITDA
4.17 6.69 5.84 6.44 7.20
EV to Sales
0.75 1.10 1.01 1.13 0.99
EV to Free Cash Flow
10.38 13.97 60.55 24.19 6.09
EV to Operating Cash Flow
6.29 9.55 17.95 14.04 5.13
Tangible Book Value Per Share
-43.27 -60.68 -64.89 -60.85 -71.60
Shareholders’ Equity Per Share
45.64 15.82 10.68 9.62 0.27
Tax and Other Ratios
Effective Tax Rate
0.08 0.19 0.26 0.22 -0.14
Revenue Per Share
237.12 202.17 179.32 182.39 167.98
Net Income Per Share
18.09 6.01 9.35 13.83 7.31
Tax Burden
0.57 0.38 0.74 0.78 1.14
Interest Burden
1.04 0.64 0.54 0.74 0.43
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.10 0.45 0.46 0.46 0.48
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
1.08 3.89 1.08 1.06 4.44
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis